Skip to content

Bills · 2019-2020 Regular Session

AB 156

Died at session end Official bill text Atom feed

Relating to: regulating the sale of prescription drugs below cost. (FE)

Drugs Drugs — Criminal acts and law enforcement Trade practice

  1. Introduced, stopped here
  2. Passes Assembly, not reached
  3. Passes Senate, not reached
  4. Governor signs, not reached
  5. Law, not reached

Unfamiliar terms? Glossary

What this bill does

Plain-language analysis by the nonpartisan Legislative Reference Bureau

This bill exempts prescription drugs from the Unfair Sales Act. Under current

law, the Unfair Sales Act, also known as the “minimum markup law,” prohibits

retailers and wholesalers from selling merchandise, including prescription drugs,

for less than the cost of the merchandise to the seller. Under the bill, the prohibition

on below-cost sales does not apply to prescription drugs.

What it would cost

Fiscal estimates filed by state agencies, as official PDFs

Sponsors

Introduced by: C. Taylor (D) , Kolste (D) , Ott (R) , Sargent (D) , Sinicki (D) , Skowronski (R)

7 cosponsors

Bernier (R) , Carpenter (D) , Feyen (R) , Jacque (R) , Kooyenga (R) , L. Taylor (D) , Risser (D)

Full history

  1. Apr 9, 2019 · Assembly

    Introduced by Representatives Ott, Skowronski, Kolste, C. Taylor, Sinicki and Sargent; cosponsored by Senators Carpenter, Kooyenga, Bernier, Feyen, Risser, Jacque and L. Taylor

  2. Apr 9, 2019 · Assembly

    Read first time and referred to Committee on Medicaid Reform and Oversight

  3. Apr 22, 2019 · Assembly

    Fiscal estimate received

  4. Apr 1, 2020 · Assembly

    Failed to pass pursuant to Senate Joint Resolution 1